| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |